Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Russia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20131
20171
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
AstraZeneca1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
Spectrum Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms2
Biliary Tract Neoplasms1
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Endometrial Neoplasms1
Ovarian Neoplasms1
Pancreatic Neoplasms1
Prostatic Neoplasms1
Recurrence1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.